Reference is made to the stock exchange announcement fromSoftOx Solutions AS (the "Company") on15 December 2021 regarding the successfully completed private placement of 915,000 new shares. The share capital increase pertaining to the private placement ofNOK 18,300 divided on 915,000 shares has today been registered in theNorwegian Register ofBusiness Enterprises (Nw: Foretaksregisteret). Following the share capital increase, the new share capital in the Company isNOK 201,669.36 divided into 10,083,468 shares, each with a nominal value ofNOK 0.02 . The new shares will be listed and tradable on Euronext Growth Oslo from issuance in theCentral Securities Depository (VPS). For further information, please contact: CEOGeir Almås ofSoftOx Solutions AS , or CFOKristine Rød ofSoftOx Solutions AS Mail: ir@soft-ox.com Mobile: (+47) 948 59 599 AboutSoftOx Solutions AS SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian BioTech company based inOslo with the aim of helping to combat major threats to human health, namely the emergence of antimicrobial resistance (AMR), biofilm infections in chronic wounds and the spread of viruses. For more information on SoftOx, visit www.soft-ox.com
Click here for more information
© Oslo Bors ASA, source